Poster: MDS-482 Impact Of Magrolimab in Combination With Azacitidine on Red Blood Cells (RBCs) in Patients With Higher-Risk Myelodysplastic Syndromes (HR MDS)

Authors :: James Chen
Lisa Johnson
Kelly McKenna
Timothy Choi
Jiaqi Duan
Dongdong Feng
Jonathan Tsai
Natalia Garcia-Martin
Kavitha Sompalli
Roy Maute
Paresh Vyas
Ravindra Majeti
Chris Takimoto
Jie Liu
Giridharan Ramsingh
Mark Chao
Jens-Peter Volkmer
Irving Weissman
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S154
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools